Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-09

Clinical Trial Update: Remimazolam vs Desflurane for General Anesthesia for Ablation of Arrhythmia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares remimazolam with desflurane for general anesthesia during ablation of arrhythmia, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DESFLURANE (DESFLURANE)
  • Remimazolam (remimazolam)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Remimazolam, Desflurane | Phase 4 | Status: COMPLETED